-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Radiofrequency Catheter Ablation for Atrial Fibrillation
Original release date
July 6, 2009
Surveillance … Report (1st Assessment/cycle 1)
November, 2011
Surveillance Report (2nd Assessment/cycle 2)
December … It was therefore due for a surveillance assessment in January,
2010. … The first surveillance assessment report
of this CER was submitted to AHRQ in November, 2011. … -130516
atrial-fibrillation-surveillance-130516.2
atrial-fibrillation-surveillance-130516.3
atrial-fibrillation-surveillance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
March 14, 2013 - ) in
Children with Juvenile Idiopathic Arthritis (JIA)
Original release date: September 2011
Surveillance … Program
AHRQ Comparative Effectiveness Review
Surveillance Program
ii
Summary Decision … Resource constraints at
the Surveillance Center delayed this until September 2012, and then late-breaking … JIA Surveillance Assesmen_ CER 28_March 14 2013_high
JIA Surveillance Assesmen_ CER 28_March 14 2013 … _high.2
JIA Surveillance Assesmen_ CER 28_March 14 2013_high.3
JIA Surveillance Assesmen_ CER 28_March
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - To Reduce Risk of
Primary Breast Cancer in Women
Original release date:
September 14, 2009
Surveillance … Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings … is Medium (This is
unchanged from the last assessment)
AHRQ Comparative Effectiveness Review
Surveillance … The Surveillance
Program commenced in late summer 2010, and the first assessment of CER #17 was submitted … Cancer Surveillance
November 2011:
Conclusion is still valid and
this portion of the CER does
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance … Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings … is Low (This is
unchanged from the last assessment)
AHRQ Comparative Effectiveness Review
Surveillance … Treatment of Patients with Cystic Fibrosis was released in October
2010.1 It was therefore due for a surveillance … The Surveillance
Program commenced in late summer 2010, and the first assessment of CER #23 was submitted
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - Disease Stages 1–3: Screening, Monitoring, and
Treatment
Original release date:
January 2012
Surveillance … Decision
This CER’s priority for updating is Low
AHRQ Comparative Effectiveness Review
Surveillance … Program
AHRQ Comparative Effectiveness Review
Surveillance Program
ii
Authors:
Alicia … 3:
Screening, Monitoring, and Treatment was released in January 2012.1 It was therefore due for a
surveillance … Questionnaire Matrix
Surveillance and Identification of Triggers for Updating Systematic Reviews
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-e-surveillance-report-1.xlsx
January 01, 2021 - Table E-1. RCT QA
Table E-1. RCT quality assessment
Author,
Year Randomization adequate? Allocation concealment adequate? Groups similar at baseline? Outcome assessors masked? Care provider masked? Patient masked? Intention-to-treat (ITT) analysis Acceptable levels of overall attrition and between-group differences…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f1-surveillance-report-1.xlsx
November 22, 2021 - Title
Appendix F - Data Abstraction of Efficacy Outcomes
NPP_Pain
Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseli…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f2-surveillance-report-1.xlsx
November 22, 2021 - Title
Appendix F2 - Data Abstraction of Harms Outcomes
TCA_PCT
WAE WAE SAE SAE Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cognitive Effects Cognitive Effects Cognitive Effects Cognitive Effects Dry Mouth Dry Mout…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-g-surveillance-report-1.xlsx
November 22, 2021 - RCTs
Author, year Randomization adequate Allocation concealment adequate Patients and personnel masked Outcome assessors masked Groups similar at baseline Intent-to-treat analysis (at least 95% analyzed) Attrition < 20%; Difference between groups <10% Avoidance of selective outcomes reporting Quality rating
Chakrabar…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_surveillance.pdf
January 30, 2013 - Report (1st Assessment/cycle 1):
May, 2012
Surveillance Report (2nd Assessment/cycle 2):
December … The first surveillance assessment report of this CER was
due for a surveillance assessment in 6 months … Saftey surveillance alerts: No new alert was identified. … CER=comparative effectiveness review;
preterm-birth-terbutaline-pump-surveillance
preterm-birth-terbutaline-pump-surveillance … .2
preterm-birth-terbutaline-pump-surveillance.3
preterm-birth-terbutaline-pump-surveillance.4
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - AHRQ Comparative Effectiveness Review
Surveillance Program
CER #31:
Effectiveness of Early Diagnosis … Report (1st assessment/cycle 1):
October 2012
Surveillance Report (2nd assessment/cycle 2):
January … for
another surveillance update in January 2014. … 51
CER 31 C difficile Surveillance Report Combined 070114 (2)_SJclean
CER 31 C difficile Surveillance … .3
CER 31 C difficile Surveillance Report Combined 070114 (2)_SJclean.4
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
April 01, 2013 - Syndrome Undergoing Percutaneous Coronary
Intervention
Original release date:
December, 2011
Surveillance … Decision
This CER’s priority for updating is Low
AHRQ Comparative Effectiveness Review
Surveillance … Resource
constraints at the Surveillance Center delayed this until April 2013. … ACS-PCI-adjunctive-devices-surveillance-130625
ACS-PCI-adjunctive-devices-surveillance-130625.2
ACS-PCI-adjunctive-devices-surveillance … -130625.3
ACS-PCI-references-surveillance-130625
ACS-PCI-adjunctive-devices-surveillance-130625.4
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
February 01, 2014 - AHRQ Comparative Effectiveness Review
Surveillance Program
CER # 22:
Comparative Effectiveness of … Report (1st Assessment/cycle 1):
February 2012
Surveillance Report (2nd Assessment/cycle 2):
November … 2012
Surveillance Report (3rd Assessment/cycle 3):
February 2014
Key Findings (1st Assessment/cycle1 … No Signal
3.3 Safety surveillance alerts [Cycle 3]
There were no safety surveillance alerts relevant … -140925
rotator-cuff-tear-surveillance-140925.2
rotator-cuff-tear-surveillance-140925.3
rotator-cuff-tear-surveillance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - Report: August 2012
Surveillance Report: April 2016
Summary of Key Findings from Surveillance Report … Methods
Prior Surveillance
A surveillance report for the original systematic review was released … Results
Prior Surveillance
Prior surveillance of the topic included 9 studies and consultation with … Prior Surveillance Assessment (August, 2012):
• Likely Current
o The prior surveillance identified … Prior Surveillance Assessment (August 2012):
• Likely Current
o The prior surveillance identified a
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
January 08, 2013 - for Evaluating
Musculoskeletal Complaints in Children
Original release date:
March, 2012
Surveillance … AHRQ Comparative Effectiveness Review
Surveillance Program
Authors:
Margaret Maglione, MPP
Susanne … assessment in September, 2012,
but resource constraints at the Surveillance Center delayed this until … ANA Surveillance Assesment_CER 50_3-1-13_low
ANA Surveillance Assesment_CER 50_3-1-13_low.2
ANA Surveillance … Assesment_CER 50_3-1-13_low.3
ANA Surveillance Assesment_CER 50_3-1-13_low.4
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-psoriatric_surveillance.pdf
March 01, 2013 - Psoriatic Arthritis Surveillance Assesment_CER 54_Low
CER #54:
Drug Therapy for Psoriatic Arthritis … in Adults:
Update of a 2007 Report
Original release date:
June 2012
Surveillance Report: … Decision
This CER’s priority for updating is Low
AHRQ Comparative Effectiveness Review
Surveillance … Psoriatic Arthritis Surveillance Assesment_CER 54_Low
Psoriatic Arthritis Surveillance Assesment_CER … 54_Low.2
Psoriatic Arthritis Surveillance Assesment_CER 54_Low.3
Psoriatic Arthritis Surveillance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
January 30, 2013 - Report (1st Assessment/cycle 1):
May, 2012
Surveillance Report (2nd Assessment/cycle 2):
December … The first surveillance assessment report of this CER was
due for a surveillance assessment in 6 months … Saftey surveillance alerts: No new alert was identified. … CER=comparative effectiveness review;
preterm-birth-terbutaline-pump-surveillance
preterm-birth-terbutaline-pump-surveillance … .2
preterm-birth-terbutaline-pump-surveillance.3
preterm-birth-terbutaline-pump-surveillance.4
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-d-surveillance-report-1.xlsx
September 30, 2015 - Appendix Table D-1. RCTs
Table D-1. Randomized controlled trials
Author, Year Study design
Duration Setting
Country Eligibility criteria Interventions Sample Characteristics Screened
Eligible
Randomized
Analyzed Results Adverse Events and Withdrawals Due To Adverse Events Sponsor Quality
Hruschak, 2021 RCT
Duration:…
-
effectivehealthcare.ahrq.gov/products/prostate-cancer-surveillance/
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-e-surveillance-report-1_0.xlsx
November 22, 2021 - Title
Appendix E - Study Characteristics
NPP
Author, Year
Country
Trial Name
Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized
N Analyzed Intervention Duration (weeks) Funding Source
Placebo-controlled
Hussain, 2021
Pakistan
Fair NPP (DPN) Age, mean: …